Core B: Biostatistics and Data Harmonization Shared Resource

核心 B:生物统计学和数据协调共享资源

基本信息

项目摘要

ABSTRACT – Core B, Biostatistics and Data Harmonization Shared Resource Strong biostatistical leadership and expertise are integral to achieving scientific integrity of research data and analytical results, and are indispensable for assuring confidence in the potential clinical or public health impact of research activities. The primary goal of Core B, the Biostatistics and Data Harmonization Shared Resource, is to oversee and guide all aspects of study design, data management and data analysis across all three P01 projects so the scientific aims of each project are addressed using standardized, high- quality datasets and the most appropriate statistical methods. We have a strong team of biostatisticians, programmer/analysts and investigators with extensive experience using the P01 data and population resources. Our resources include the California and Utah Cancer Registries linked to hospitalization, emergency and ambulatory surgery data; the University of North Carolina at Chapel Hill Cancer Information & Population Health Resource; the integrated healthcare systems of Kaiser Permanente Northern California and Southern California; and survey data on a population subset. The varying data sources present several challenges in cleaning, analysis and interpretation, including the potential for reverse causation and various forms of selection bias. Biostatistical consultation provided by the Core will ensure the appropriate application of approaches to determine the potential magnitude of such biases and methods to account for them. The specific aims of the Core are to: 1. Provide overall biostatistical leadership, consultation and support across all three P01 projects and Core C, the Survey Shared Resource; 2. Carry out cohort identification to meet the subject inclusion criteria for each aim of each project and for the survey described in Core C; 3. Harmonize and standardize variable definitions used across data sources and projects; 4. Construct and provide study analytic datasets that incorporate data from clinical and administration data sources, cancer registries, and patient surveys; 5. Oversee analyses using appropriate methods to achieve the aims of each project, including consideration of systematic biases, potential confounders, and sampling weights in the analysis of survey data. To carry out the objectives of this P01, centralized biostatistical expertise and services will ensure use of common concepts and data definitions throughout the P01. This Core will ensure that data are appropriate for the questions addressed, harmonized across source data systems to enhance comparability, and analyzed and interpreted with knowledge of strengths and limitations. This strategy will maximize the potential impact of P01 findings to inform and improve healthcare for adolescent and young adult cancer survivors.
摘要-核心B,生物统计学和数据协调共享资源 强大的生物统计领导力和专业知识是实现研究科学完整性的必要条件 数据和分析结果,并且对于确保潜在临床或公众的信心是不可或缺的 研究活动对健康的影响。核心B的主要目标是生物统计和数据协调 共享资源,监督和指导研究设计、数据管理和数据分析的各个方面 在所有三个P01项目中,每个项目的科学目标都是使用标准化的,高 质量数据集和最合适的统计方法。我们有一个强大的生物统计学家团队, 使用P01数据和人群具有丰富经验的程序员/分析员和研究者 资源我们的资源包括加州和犹他州癌症登记与住院, 急诊和门诊手术数据;北卡罗来纳州大学查佩尔山癌症信息与 人口健康资源;北方加州和 南加州;和调查数据的人口子集。不同的数据源提供了几个 清洁、分析和解释方面的挑战,包括反向因果关系的可能性和各种 选择偏差的形式。核心提供的生物统计咨询将确保适当的应用 确定这种偏差的潜在程度的方法和解释这些偏差的方法。的 核心的具体目标是: 1.为所有三个P01项目提供全面的生物统计领导、咨询和支持, 核心C,调查共享资源; 2.进行队列识别,以满足每个项目的每个目标的受试者入选标准, 核心C中描述的调查; 3.统一和标准化跨数据源和项目使用的变量定义; 4.构建并提供包含临床和管理数据的研究分析数据集 数据来源、癌症登记和患者调查; 5.使用适当的方法监督分析,以实现每个项目的目标,包括 在分析中考虑系统偏倚、潜在混杂因素和抽样权重, 调查数据 为了实现本P01的目标,集中的生物统计专业知识和服务将确保使用 P01中的通用概念和数据定义。该核心将确保数据是适当的 对于所解决的问题,在源数据系统之间进行协调,以提高可比性,并进行分析 并以优势和局限性的知识进行解释。这一战略将最大限度地发挥 P01调查结果为青少年和年轻成年癌症幸存者提供信息和改善医疗保健。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles Quesenberry其他文献

Charles Quesenberry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles Quesenberry', 18)}}的其他基金

Core B: Biostatistics and Data Harmonization Shared Resource
核心 B:生物统计学和数据协调共享资源
  • 批准号:
    10477021
  • 财政年份:
    2020
  • 资助金额:
    $ 13.96万
  • 项目类别:
Core B: Biostatistics and Data Harmonization Shared Resource
核心 B:生物统计学和数据协调共享资源
  • 批准号:
    10263884
  • 财政年份:
    2020
  • 资助金额:
    $ 13.96万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.96万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了